Department of Pharmacology

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.

Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery.

An association between rigid-compulsive behaviors and gastrointestinal symptoms in autism spectrum disorder may point to a common biological pathway that impacts both the brain and the gut.

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.

A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care.